Q2 2020

The effect of hyperlactatemia timing on the outcomes after cardiac surgery

Khaled D. Algarni
10.1186/s43057-020-00029-w 378 المشاهدات 10 الاقتباسات
10
الاقتباسات
378
المشاهدات
الملخص

AbstractBackgroundSeveral studies linked postoperative hyperlactatemia to worse outcomes in adult patients undergoing cardiac surgery. However, data on the effect of timing of hyperlactatemia on outcomes are scarce. We sought to determine the prevalence of early hyperlactatemia (EHL) and its impact on clinical outcomes compared to late hyperlactatemia (LHL) in patients undergoing ACS procedures.ResultsWe included 305 consecutive adult patients who underwent cardiac surgery procedures between July 2017 and Nov 2019 at a single institution. Lactate level was measured in the first 10 h after surgery and EHL was defined as lactate level > 3 mmol/L in the first hour after surgery. Logistic regression analysis was performed to determine predictors of EHL. Seventeen percent (n= 52) had EH while 83% (n= 253) did not. Patients with EHL had significantly longer cardiopulmonary bypass (P= 0.001) and cross-clamp (P= 0.001) times due to increased surgical complexity in this group. Early hyperlactatemia was associated with increased post-operative extracorporeal membrane oxygenation (ECMO) support (0% vs 5.7%,P< 0.001), longer intensive care unit stay (P= 0.004), and increased hospital mortality (0% vs. 3.8%,P= 0.009). Cardiopulmonary bypass time (OR 1.001; 95% CI 1.011–1.012,P= 0.02) and glucose level (OR 1.2; 95% CI 1.1–1.3,P= 0.003) were independently associated with increased rate of EHL. In contrast, diabetes mellitus (OR 0.26; 95% CI 0.12–0.55,P< 0.001) significantly attenuated the rate of EHL.ConclusionsEarly hyperlactatemia after cardiac surgery was associated with increased morbidity and mortality. Late hyperlactatemia was very common and had a self-limiting and benign course.

الاستشهاد بهذا المقال (APA)
Khaled, D. A. (2020). The effect of hyperlactatemia timing on the outcomes after cardiac surgery. The Cardiothoracic Surgeon. https://doi.org/10.1186/s43057-020-00029-w
أبحاث ذات صلة
Requirement of artificial intelligence technology awareness for thoracic surgeons
Anshuman Darbari; Krishan Kumar; Shubhankar Darbari; Prashant L. Patil · 2021
26
استشهاد
389
Requirement of artificial intelligence technology awareness for thoracic surgeons
Anshuman Darbari; Krishan Kumar; Shubhankar Darbari; Prashant L. Patil · 2021
26
استشهاد
390
Cardiac myxomas: a review of current treatment approaches and emerging molecular therapies
Patrick Ashinze; Suvam Banerjee; Emmanuel Egbunu; Wuraola Salawu; Abdullaah Idri · 2024
18
استشهاد
389
Cardiac myxomas: a review of current treatment approaches and emerging molecular therapies
Patrick Ashinze; Suvam Banerjee; Emmanuel Egbunu; Wuraola Salawu; Abdullaah Idri · 2024
18
استشهاد
392
Recent advancements in pediatric cardiopulmonary bypass technology for better outcomes of pediatric …
Yasir Saleem; Anshuman Darbari; Rahul Sharma; Amit Vashisth; Anish Gupta · 2022
16
استشهاد
391
الوصول
عرض النص الكامل عبر DOI
نُشر في
الرقم الدولي ISSN 2662-2203
الربعية Q2
درجة المؤشر القياس العربي 72
التخصص Medicine & Health Sciences
الناشر Springer (Biomed Central Ltd.)
الدولة 🇪🇬 Egypt
عرض ملف المجلة →
المؤلفون
تفاصيل النشر
السنة 2020
اللغة English
أُضيف في 24 Aug 2026